Literature DB >> 15319576

COMT gene polymorphism is associated with declarative memory in adulthood and old age.

Cindy M de Frias1, Kristina Annerbrink, Lars Westberg, Elias Eriksson, Rolf Adolfsson, Lars-Göran Nilsson.   

Abstract

Variation in memory performance is to a large extent explained by genes. In the prefrontal cortex, the catechol O-methyltransferase (COMT) gene is essential in the metabolic degradation of dopamine, a neurotransmitter implicated in cognitive functions. The present study examined the effect of a polymorphism in the COMT gene on individual differences and changes in memory in adulthood and old age. Tests assessing episodic and semantic memory were administered to 286 men (initially aged 35-85 years) from a random sample of the population (i.e., the Betula prospective cohort study) at two occasions followed over a 5-year period. Carriers of the Met/Met genotype (with low enzyme activity) performed better on episodic and semantic memory, as compared to carriers of the Val allele (with higher enzyme activity). Division of episodic memory into its recall and recognition components showed that the difference was specific to episodic recall, not recognition tasks; an effect that was observed across three age groups (middle-age, young-old, and old-old adults) and over a 5-year period. The COMT gene is a plausible candidate gene for memory functioning in adulthood and old age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319576     DOI: 10.1023/B:BEGE.0000038491.06972.8c

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  55 in total

1.  The roles of COMT val158met status and aviation expertise in flight simulator performance and cognitive ability.

Authors:  Q Kennedy; J L Taylor; A Noda; M Adamson; G M Murphy; J M Zeitzer; J A Yesavage
Journal:  Behav Genet       Date:  2010-12-31       Impact factor: 2.805

2.  An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories.

Authors:  Pingyuan Gong; Zijian Zheng; Wanyu Chi; Xu Lei; Xiaodong Wu; Dongmei Chen; Kejin Zhang; Anyun Zheng; Xiaocai Gao; Fuchang Zhang
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

3.  Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.

Authors:  M V Alfimova; V E Golimbet; I K Gritsenko; T V Lezheiko; L I Abramova; M A Strel'tsova; I V Khlopina; R Ebstein
Journal:  Neurosci Behav Physiol       Date:  2007-09

Review 4.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  COMT Val158Met and cognition: main effects and interaction with educational attainment.

Authors:  M-A Enoch; J F Waheed; C R Harris; B Albaugh; D Goldman
Journal:  Genes Brain Behav       Date:  2008-11-26       Impact factor: 3.449

Review 6.  Preventing neurocognitive late effects in childhood cancer survivors.

Authors:  Martha A Askins; Bartlett D Moore
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

7.  The COMT Val158Met polymorphism and cognition in depressed and nondepressed older adults.

Authors:  G G Potter; W D Taylor; D R McQuoid; D C Steffens; K A Welsh-Bohmer; K R R Krishnan
Journal:  Int J Geriatr Psychiatry       Date:  2009-10       Impact factor: 3.485

8.  Catechol O-methyltransferase (COMT) VAL158MET functional polymorphism, dental mercury exposure, and self-reported symptoms and mood.

Authors:  Nicholas J Heyer; Diana Echeverria; Michael D Martin; Federico M Farin; James S Woods
Journal:  J Toxicol Environ Health A       Date:  2009

Review 9.  Genes, cognition and brain through a COMT lens.

Authors:  D Dickinson; B Elvevåg
Journal:  Neuroscience       Date:  2009-05-13       Impact factor: 3.590

10.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.